Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease

CONCLUSIONS: The seroconversion rate was low for LAV at six months after a single dose of IVIG for KD, but seroconversion was achievable with a booster vaccination at 12 months.CLINICAL TRIAL REGISTRATION: UMIN-CTR, UMIN000007174, https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000008452.PMID:34452773 | DOI:10.1016/j.vaccine.2021.07.097

Source: Vaccine - August 28, 2021 Category: Allergy & Immunology Authors: Yoshihiko Morikawa Hiroshi Sakakibara Takahisa Kimiya Toshimasa Obonai Masaru Miura Tokyo Pediatric Clinical Research Network Source Type: research